Trends’inthe’pharmaceutical’industry I3 HEALTH（趋势inthe pharmaceutical industry I3健康）.pdf

Trends in the pharmaceutical industry Presentation to I3H ULB Jan.16 1 Hystorical evolution of value added – Economic / market Pharma companies had several periods and adapted the value creation model The great success of blockbuster model delayed need for cost optimizations n The global blockbuster market has historically experienced high growth rates (1994-2000 CAGR: 23.6%). Such success underpins the overall revenue performance of most of the companies that currently market blockbusters. Blockbusters offer higher returns than their lower value counterparts Added relative to the substantial risks, time and costs involved in Value product development and commercialization n This boost in added value experienced by the pharmaceutical industry is only a temporary effect; as the blockbusters that have driven the value growth are heading towards their end of patent protection, industry value will